Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zeichner

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
The Journal of Dermatological Treatment|June 21, 2023
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trialsZoe D Draelos, Emil A Tanghetti, Leon H Kircik, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2024
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient JourneyHilary Baldwin, Julie C Harper, Joshua A Zeichner, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to TreatSteven R Feldman, George Han, Valerie D Callender, et al.
Journal of Drugs in Dermatology : JDD|July 8, 2015
Total Defense + Repair: A Novel Concept in Solar Protection and Skin RejuvenationDavid H McDaniel, Iltefat H Hamzavi, Joshua A Zeichner, et al.
Cutis|November 6, 2010
Optimizing topical therapies for treating psoriasis: a consensus conferenceJoshua A Zeichner, Mark G Lebwohl, Alan Menter, et al.
The Journal of Dermatological Treatment|November 16, 2022
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skinEmil A Tanghetti, Joshua A Zeichner, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD|January 8, 2016
Rejuvenating Hydrator: Restoring Epidermal Hyaluronic Acid Homeostasis With Instant BenefitsVic A Narurkar, Sabrina G Fabi, Vivian W Bucay, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2025
Assessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month AnalysisMahmoud Ghannoum, Ahmed Eltokhy, James Sewake, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
The Journal of Dermatological Treatment|June 21, 2023
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trialsZoe D Draelos, Emil A Tanghetti, Leon H Kircik, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2024
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient JourneyHilary Baldwin, Julie C Harper, Joshua A Zeichner, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to TreatSteven R Feldman, George Han, Valerie D Callender, et al.
Journal of Drugs in Dermatology : JDD|July 8, 2015
Total Defense + Repair: A Novel Concept in Solar Protection and Skin RejuvenationDavid H McDaniel, Iltefat H Hamzavi, Joshua A Zeichner, et al.
Cutis|November 6, 2010
Optimizing topical therapies for treating psoriasis: a consensus conferenceJoshua A Zeichner, Mark G Lebwohl, Alan Menter, et al.
The Journal of Dermatological Treatment|November 16, 2022
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skinEmil A Tanghetti, Joshua A Zeichner, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD|January 8, 2016
Rejuvenating Hydrator: Restoring Epidermal Hyaluronic Acid Homeostasis With Instant BenefitsVic A Narurkar, Sabrina G Fabi, Vivian W Bucay, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2025
Assessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month AnalysisMahmoud Ghannoum, Ahmed Eltokhy, James Sewake, et al.
Pageof 10